HomeAUPH • NASDAQ
Aurinia Pharmaceuticals Inc
Follow
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 59.87M | 32.76% |
Operating expense | 26.63M | -59.07% |
Net income | 1.43M | 105.32% |
Net profit margin | 2.39 | 104.01% |
Earnings per share | 0.01 | 105.26% |
EBITDA | 24.44M | 179.82% |
Effective tax rate | -21.82% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 358.44M | 2.30% |
Total assets | 550.65M | 0.47% |
Total liabilities | 173.17M | 1.80% |
Total equity | 377.48M | — |
Shares outstanding | 137.34M | — |
Price to book | 3.03 | — |
Return on assets | 8.90% | — |
Return on capital | 10.50% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.43M | 105.32% |
Cash from operations | 30.11M | 110.41% |
Cash from investing | 39.22M | 726.87% |
Cash from financing | -23.05M | -313.23% |
Net change in cash | 46.29M | 1,768.08% |
Free cash flow | 49.37M | 366.11% |
Previous close
$8.11
Day range
$8.13 - $8.32
Year range
$4.71 - $10.67
Market cap
1.19B USD
Avg Volume
1.59M
P/E ratio
210.09
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2012
Headquarters
Website
Employees
130
